Our Services

Vein Treatments
Spider Vein Treatments

Sclerotherapy

Painless and scar free vein treatment

Sclerotherapy involves injecting a "sclerosant" directly into each vein with very fine needles. The sclerosant used acts as a detergents by washing away the lining of the vein allowing the two walls to stick together is know as Fibrovein (sodium tetradecyl sulphate - STS).

Sclerotherapy was introduced in the 1920s and made popular in the 1960s using STS when it was shown to be effective for non-saphenous varicosities. Polidocanol was introduced into Australia some 10 years ago and has been extensively investigated here in a trial involving more than 30,000 patients.

Sclerotherapy is used to treat smaller veins that are not associated with reflux into the main saphenous veins and also to treat residual veins left after other forms of treatment. Most patients can expect at least a 75 percent improvement in the appearance of their legs.

Multiple treatment sessions are frequently required. It may take up to 3 months to show maximum benefit after one treatment session. Perfection cannot be guaranteed.

EVLT

Latest Technology

EVLT uses laser energy delivered in a thin fibre-optic probe to treat the underlying cause of the varicose veins. Prformed under ultrasound guidance and local anesthesia allows a more gentle "minimally invasive" approach to the treatment of varicose veins. There is minimal pain and virtually no scarring.

UGS

UGS has been in use for some 25 years.

UGS is used to block off smaller diameter saphenous veins or large tributaries by injection using ultrasound to guide the needle to the vein. Our results published in the European Journal of Vascular Surgery show a low risk of complications and good results but with a need to repeat treatment at a later date in some patients. Success rates for UGS compare favourably to published results for surgery. The two sclerosants used are Aethoxysklerol (polidocanol) or Fibrovein (sodium tetradecyl sulphate - STS). Both are detergents and act by washing away the lining of the vein allowing the two walls to stick together.

Worldwide the trend in recent years has been to use sclerosant made up as foam. However, it is now known that this can lead to bubbles passing to the brain and there is a small number of reported strokes. Accordingly, this practice has reverted to liquid sclerotherapy. However this may lead to a need for greater numbers of treatment sessions